exploratory study for dilated cardiomyopathy using YS0001

exploratory study for dilated cardiomyopathy using YS0001 - exploratory study for dilated cardiomyopathy using YS0001

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000015892

Enrollment

Registered

2014-12-10

Start date

2014-11-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dilated cardiomyopathy

Interventions

Culture of autologous skeletal myoblasts and engineering myoblast sheets. Transplantation of myoblast sheets to heart

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: DCM NYHA Class => iii Ejection fraction =<35%

Exclusion criteria

Exclusion criteria: skeletal muscle disease active infection (HIV,HBV,HCV,HTLV-1) Cancer within the past 5 years

Design outcomes

Primary

Measure	Time frame
LVEF change at 26 week from treatment	—

Countries

Japan

Contacts

Public ContactShigeru Miyagawa

Osaka University hospital Osaka University hospital

miyagawa@surg1.med.osaka-u.ac.jp06-6879-3154

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026